Literature DB >> 14526468

[Avian pathogenic Escherichia coli (APEC)].

Christa Ewers1, Traute Janssen, Lothar H Wieler.   

Abstract

Infections with avian pathogenic Escherichia coli (APEC) cause colibacillosis, an acute and mostly systemic disease resulting in significant economic losses in poultry industry worldwide. Avian colibacillosis is a complex syndrome characterized by multiple organ lesions with airsacculitis and associated pericarditis, perihepatitis and peritonitis being most typical. Environmental factors as well as the constitution of poultry or initial viral infections influence the outcome of APEC-infections. However, several challenge experiments in chickens proofed the role of virulent APEC strains as the single aetiological agent. Currently serotypes O1:K1, O2:K1 and O78:K80 are recognized as the most prevalent, however the number of published serotypes is increasing. In addition, single APEC isolates vary profoundly in virulence, and knowledge about the molecular basis of this variability is still scarce. Known virulence factors of APEC are adhesins (F1- and P-fimbriae), iron acquisition systems (aerobactin and yersiniabactin), hemolysins (hemolysinE and temperaturesensitive hemagglutinin), resistance to the bactericidal effects of serum and phagocytosis (outer membrane protein, iss protein, lipopolysaccharide, K/1)-capsule and colilcin production) as well as toxins and cytotoxins (heat stable toxin, cyto-/verotoxin and flagella toxin). Esperimental studies have shown that the respiratory tract, principally the gas-exchange region of the lung and the interstitium of the air sacs are the most important sites of entry for avian pathogenic E. coli. APEC strains adhere to the epithelial cells of air sacs presumably through F1-fimbriae. After colonization and multiplication the bacteria enter the bloodstream, and the temperature-sensitive hemagglutinin (tsh) seems to be important int his step. After invading the bloodstream APEC cause a septicemia resulting in massive lesins in multiple internal organs and in sudden death of the birds. The ability of the bacteria to acquire iron and the resistance to the bactericidal effects of serum, predominantly conferred by the increased serum survival (iss)--protein, enables APEC to multiply quickly in their hosts. Iss is regarded a specific genetic marker for avian pathogenic E. colistrains. A critical review of the literature published so far on APEC reveals, that these pathotypes are not defined appropriately. This findings urge investigations on the population structure of APEC, enabling the establishment of appropriate diagnostic tools and avoiding the obsolete use of serotyping for APEC diagnosis. So far more than 20 APEC strains have been investigated in animal experiments, explaining contrary published results. Thus, the lack of knowledge in pathogenicity and in immunity of APEC infections urges further experimental studies. As APEC share not only identical serotypes with human pathogens but also specific virulence factors, their zoonotic potential is under consideration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14526468

Source DB:  PubMed          Journal:  Berl Munch Tierarztl Wochenschr        ISSN: 0005-9366            Impact factor:   0.328


  36 in total

1.  Identification of genes required for avian Escherichia coli septicemia by signature-tagged mutagenesis.

Authors:  Ganwu Li; Claudia Laturnus; Christa Ewers; Lothar H Wieler
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

2.  Effects of ibeA deletion on virulence and biofilm formation of avian pathogenic Escherichia coli.

Authors:  Shaohui Wang; Chunling Niu; Zhenyu Shi; Yongjie Xia; Muhammad Yaqoob; Jianjun Dai; Chengping Lu
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Complete genome sequence of the novel Escherichia coli phage phAPEC8.

Authors:  J Tsonos; E M Adriaenssens; J Klumpp; J-P Hernalsteens; R Lavigne; H De Greve
Journal:  J Virol       Date:  2012-12       Impact factor: 5.103

4.  Development and evaluation of a dot blot assay for rapid determination of invasion-associated gene ibeA directly in fresh bacteria cultures of E. coli.

Authors:  Chunling Niu; Shaohui Wang; Chengping Lu
Journal:  Folia Microbiol (Praha)       Date:  2012-06-07       Impact factor: 2.099

5.  Intestine and environment of the chicken as reservoirs for extraintestinal pathogenic Escherichia coli strains with zoonotic potential.

Authors:  Christa Ewers; Esther-Maria Antão; Ines Diehl; Hans-C Philipp; Lothar H Wieler
Journal:  Appl Environ Microbiol       Date:  2008-11-07       Impact factor: 4.792

6.  Suppression subtractive hybridization identifies an autotransporter adhesin gene of E. coli IMT5155 specifically associated with avian pathogenic Escherichia coli (APEC).

Authors:  Jianjun Dai; Shaohui Wang; Doreen Guerlebeck; Claudia Laturnus; Sebastian Guenther; Zhenyu Shi; Chengping Lu; Christa Ewers
Journal:  BMC Microbiol       Date:  2010-09-09       Impact factor: 3.605

Review 7.  Origins and virulence mechanisms of uropathogenic Escherichia coli.

Authors:  Travis J Wiles; Richard R Kulesus; Matthew A Mulvey
Journal:  Exp Mol Pathol       Date:  2008-04-08       Impact factor: 3.362

Review 8.  Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.

Authors:  Amelia E Barber; J Paul Norton; Travis J Wiles; Matthew A Mulvey
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-02       Impact factor: 11.056

9.  Pathotype and antibiotic resistance gene distributions of Escherichia coli isolates from broiler chickens raised on antimicrobial-supplemented diets.

Authors:  Claudie Bonnet; Fatoumata Diarrassouba; Roland Brousseau; Luke Masson; Edward Topp; Moussa S Diarra
Journal:  Appl Environ Microbiol       Date:  2009-09-11       Impact factor: 4.792

10.  Comparative Pathogenomics of Escherichia coli: Polyvalent Vaccine Target Identification through Virulome Analysis.

Authors:  J R Clark; A M Maresso
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.